• NeoStem, Inc. Signs a Definitive Agreement to Divest Its 51% Ownership Interest in Suzhou Erye Pharmaceuticals Company Ltd. More...

• Braun Beteiligungs GmbH (BBG) Invests in Enzymicals AG More...

• Myriant Receives $25 Million Award Under USDA's Business and Industry (B&I) Loan Guarantee Program to Develop Bio-based Chemicals More...

• Merck & Co., Inc. (MRK) Bets Up to $303 Million on Ambrx, Inc.'s "Smart Bomb" Antibodies More...

• Takeda Pharmaceutical Co. Ltd. (TKDG.DE) to Stop Selling 13 Pfizer Inc. (PFE) Drugs in Japan More...

• KineMed, Inc. Announces Biomarker Discovery Collaboration With GlaxoSmithKline (GSK) More...

• Horizon Pharma, Inc. and Mallinckrodt Inc., the Pharmaceuticals Business of Covidien (COV), Enter Into Co-Promotion Agreement for DUEXIS® in the United States More...

• Bavarian Nordic (BAVA.CO) Awarded Contract From the U.S. Governmentto Advance the Development of New MVA-BN® Based Vaccines More...

• World Renowned Physicians Join AdeTherapeutics Clinical Team More...

• Dave Holly Joins Bilcare Global Clinical Supplies (Europe) Ltd. as Senior Project Manager, IVR/IWR Services More...

• BioAlliance Pharma Reinforces Its Development Team with the Appointment of Louis Kayitalire, MD, as Head of Research and Development More...

• Inovio Pharmaceuticals (INO) Appoints International Management Expert Dr. Angel Cabrera to its Board of Directors More...

• FBI Lab Veteran Dr. Joseph A. DiZinno to Lead IntegenX New D.C. Office as Senior Director of Federal Programs More...

• China Botanic Pharmaceutical Inc. (Formerly known as Renhuang Pharmaceuticals Inc.) Schedules Conference Call to Discuss Second Quarter Fiscal Year 2012 Results More...

• Johnson & Johnson (JNJ) to Host Analyst Conference Call on Second-Quarter Results More...

• Polydex Pharmaceuticals (POLXF) Issues First Quarter Financial Results More...

• Illumina, Inc. (ILMN) Files Second Patent Infringement Suit Against Complete Genomics, Inc. More...

• Waters Corporation (WAT) Breaks Ground on New Mass Spectrometry HQ in Wilmslow, UK More...

• Toxic Side Effects With Onyx Pharmaceuticals, Inc. (ONXX) Drug: FDA More...

• FDA Staff Question Value of Sanofi (France) (SAN.PA) Blood Clot Drug More...

• Genta Incorporated (GETA.OB) Announces Agreement With FDA on Special Protocol Assessment of Phase 3 Trial of Tesetaxel as Initial Chemotherapy for Women With Metastatic Breast Cancer More...

• Pharming Group (PHGUF.PK) Announces Presentation of New Ruconest(R) Clinical Data More...

• Bristol-Myers Squibb Company (BMY) Release: Six-Year Follow-Up Data for SPRYCEL® (dasatinib) 100 mg Once Daily Demonstrates 71 Percent Overall Survival in Patients with Chronic-Phase Chronic Myeloid Leukaemia Resistant or Intolerant to Imatinib More...

• Infinity Pharmaceuticals Inc. (INFI) Pulls Plug on Cancer Drug Saridegib Trials, Shares Plunge -1.20(8.68%) @ 12:46PM EDT More...

• Sanofi Pasteur (SASY.PA) Recalls Tuberculosis Vaccine Over Contamination Concerns More...

• Orexo AB Reports Regulatory Approval of Edluar® in Europe More...

• Cook Pharmica LLC Receives Milestone FDA Approval for Commercial Manufacturing More...

• Vitamin D Plus Calcium Tied to Longer Life, Aarhus University Study More...

• Antioxidant Shown to Reduce Blindness Risk in Extremely Premature Babies,Brigham and Women's Hospital Study More...

• Internet Usage Patterns Could Signal Depression, Missouri University of Science and Technology Study More...

• Vermillion PAD Intended Use Study Presented at Society for Vascular Medicine 23rd Annual Scientific Sessions More...

• Ariad Pharmaceuticals, Inc. (ARIA) Announces Updated Data From Pivotal PACE Trial of Ponatinib, its Investigational Pan-BCR-ABL Inhibitor More...

• Merck & Co., Inc. (MRK) Loses Nasonex Patent Case More...

• NeurogesX, Inc. (NGSX) Issued Japanese Patent for NGX-1998 More...

• Celladon Corporation Receives Notice of Allowance from European Patent Office More...

• iBio, Inc. (IBIO) Announces Important Expansion of its Intellectual Property Portfolio: Allowance of Patent for Anthrax Vaccines and Further Application of Modulator Platform More...

• Procter & Gamble (PG) Release: ZzzQuil™ Relieves Occasional Sleeplessness More...